PRMT1 and cancer: Despite the therapeutic challenges in targeting it, the ongoing development of selective inhibitors and an enhanced comprehension of its actions provide PRMT1‐directed methods, particularly combination therapies, a potential new approach for addressing a wide range of malignant tumors.